Has anyone had the genetic testing before chemotherapy that is called DYPD come back abnormal? Says that the chemo...

DPD Testing and Chemotherapy Safety

Yes, this is a real and important concern that oncologists take seriously. Let me explain what's happening and what you should know.

What DPD Testing Means

DPD (dihydropyrimidine dehydrogenase) is an enzyme your body uses to break down certain chemotherapy drugs, particularly fluoropyrimidines like 5-FU, capecitabine (Xeloda), and tegafur.

If you have a DPD deficiency (abnormal test):

• Your body cannot properly metabolize these drugs
• The chemotherapy can accumulate to toxic levels in your system
• This creates serious risk for severe, potentially life-threatening side effects (organ damage, severe infections, death)

This is not rare enough to ignore — studies suggest 3-5% of people have some level of DPD deficiency.

Why This Matters Clinically

According to NCCN (National Comprehensive Cancer Network) Guidelines and FDA guidance, DPD testing is now recommended BEFORE starting fluoropyrimidine chemotherapy because:

• Patients with deficiencies have experienced fatal toxicity from standard doses
• The risk is preventable with testing and dose adjustment
• Many oncology centers now screen routinely

What Happens If Your Test Is Abnormal

Your oncologist has several options:

1. Avoid fluoropyrimidines entirely — switch to different chemotherapy drugs
2. Significantly reduce the dose — if the drug is essential for your cancer type
3. Use alternative regimens — other drug combinations that don't rely on DPD metabolism
4. Enhanced monitoring — if proceeding with caution

The key point: An abnormal DPD result does NOT mean you can't have chemotherapy. It means your specific planned regimen needs to change.

Questions to Ask Your Oncologist RIGHT NOW

1. "My DPD test came back abnormal. Which chemotherapy drugs was my original plan using?"
2. "What alternative chemotherapy regimens would be appropriate for my cancer type?"
3. "If fluoropyrimidines are essential, what dose adjustments would you recommend?"
4. "How will you monitor me if we proceed with any fluoropyrimidine-based treatment?"
5. "Are there clinical trials for my cancer type using non-fluoropyrimidine regimens?"

Important Context

• This is a known, manageable issue — not a reason to panic, but a reason to act
• Your oncologist should already know about DPD deficiency protocols
• If they seem dismissive of the abnormal result, get a second opinion
• The American Cancer Society and NCCN both emphasize the importance of this testing

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Is your oncologist already discussing alternative treatment plans with you?